Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Parent topics
Antibiotic resistance and the development of new drugs
Pharmaceutical makers and biopharmaceutical companies
This topic
Recent activity
You must be
signed in
to add and move topics and links.
2019-06 University of Wisconsin study on delay in the use of new antibiotics
Pharmaceutical makers, antibiotic resistance and the development of new drugs
2019-07 Appili, the Department of Defense and the ATI-1503 antibiotic program
Pharmaceutical makers, antibiotic resistance and the development of new drugs
2019-07 FDA approval of imipenem/cilastatin plus relebactam
Antibiotic-resistant urinary tract infections (UTIs)
Imipenem-cilastatin-relebactam
Pharmaceutical makers, antibiotic resistance and the development of new drugs
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
Antibiotic-resistant urinary tract infections (UTIs)
Pharmaceutical makers, antibiotic resistance and the development of new drugs
United States Department of Defense (DoD)
United States Department of Health and Human Services (HHS)
2019-10 University of Pittsburg study on new antibiotics for carbapenem-resistant Enterobacteriaceae
Carbapenem-resistant Enterobacteriaceae (CRE)
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Antibiotic resistance and pharmaceutical business models
Business practices of pharmaceutical makers
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI
https://www.prnewswire.com/news-releases/acurx-successfully-completes-ph1-clinical-trial-for-acx-362e-in-cdi-300908613.html
ACX-362E
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Antibiotics Aren’t Profitable Enough for Big Pharma to Make More
https://www.bloomberg.com/news/articles/2019-05-03/antibiotics-aren-t-profitable-enough-for-big-pharma-to-make-more
2019-04 Achaogen files for bankruptcy
Carbapenem-resistant Enterobacteriaceae (CRE)
Pharmaceutical makers, antibiotic resistance and the development of new drugs
As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
https://morningconsult.com/2019/09/05/as-threat-of-antibiotic-resistance-mounts-biotechs-are-running-out-of-cash-and-time/
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
DISARM Act model legislation
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Working to Fight AMR
Basilea announces positive results of phase 3 TARGET study with antibiotic ceftobiprole in the treatment of acute bacterial skin and skin structure infections (ABSSSI) | Small Molecules | News Channels
https://pipelinereview.com/index.php/2019080671964/Small-Molecules/Basilea-announces-positive-results-of-phase-3-TARGET-study-with-antibiotic-ceftobiprole-in-the-treatment-of-acute-bacterial-skin-and-skin-structure-infections-ABSSSI.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Biopharm firm tackling antibiotic resistance closes funding round - The Scotsman
https://www.scotsman.com/business/biopharm-firm-tackling-antibiotic-resistance-closes-funding-round-1-4994521
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Bitter pill: the truth about antibiotics | York Press
https://www.yorkpress.co.uk/news/17685126.bitter-pill-the-truth-about-antibiotics/
Overviews of antibiotic resistance
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Business of Health Care - New Antibiotics | KWBU
https://www.kwbu.org/post/business-health-care-new-antibiotics
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Debiopharm Awarded $2.1 Million From CARB-X in the Fight Against a Highly Resistant Nosocomial-Pneumonia Causing Superbug
https://finance.yahoo.com/news/debiopharm-awarded-2-1-million-123500032.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Doctor’s day: Big bugs, big drugs, big bucks!
https://timesofindia.indiatimes.com/blogs/Masquerader/doctors-day-big-bugs-big-drugs-big-bucks/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
EFPIA responds to EC President-elect prioritization of antimicrobial r
https://www.thepharmaletter.com/article/efpia-responds-to-ec-president-elect-prioritization-of-antimicrobial-resistance
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Entasis Therapeutics Announces New Results Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs at ASM Microbe 2019 | BioSpace
https://www.biospace.com/article/entasis-therapeutics-announces-new-results-supporting-advancement-of-multiple-pathogen-targeted-antimicrobial-programs-at-asm-microbe-2019-/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Fighting antimicrobial resistance requires new diagnostic tools - STAT
https://www.statnews.com/2019/10/24/antimicrobial-resistance-fight-requires-new-diagnostic-tools/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Rapid testing, diagnostics and identification of cause of infection
Firms to work together on superbugs in China
https://www.thepharmaletter.com/article/firms-to-work-together-on-superbugs-in-china
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Fluoroquinolone Antibiotics Pose a Huge Health Risk. Why Are Doctors Still Prescribing Them?
https://www.thedailybeast.com/fluoroquinolone-antibiotics-pose-a-huge-health-risk-why-are-doctors-still-prescribing-them
Antimicrobial stewardship
Fluoroquinolones
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Franco-German collaboration on novel antibiotics
https://www.thepharmaletter.com/article/franco-german-collaboration-on-novel-antibiotics
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
https://finance.yahoo.com/news/harrow-health-forms-stowe-pharmaceuticals-113000361.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
How can economics tackle the issue of antimicrobial resistance?
https://www.openaccessgovernment.org/issue-of-antimicrobial-resistance/64575/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
IDSA board member urges Congressional effort to stabilize antibiotic market, encourage new drugs - Homeland Preparedness News
https://homelandprepnews.com/stories/34659-idsa-board-member-urges-congressional-effort-to-stabilize-antibiotic-market-encourage-new-drugs/
Infectious disease (ID)
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New Antimicrobials One of the Potential Solutions to Resistant Superbugs - WHO
https://finance.yahoo.com/news/antimicrobials-one-potential-solutions-resistant-121700233.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New FDA-Cleared Microbicidal Liquid Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact
https://finance.yahoo.com/news/fda-cleared-microbicidal-liquid-kills-173500937.html
Multi-drug resistant Candida auris
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | BioSpace
https://www.biospace.com/article/releases/new-studies-highlight-activity-of-xerava-against-gram-negative-and-gram-positive-clinical-isolates-including-multidrug-resistant-pathogens/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | Business Wire
https://www.businesswire.com/news/home/20190624005075/en/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New antibiotics aren't being made. That could cause 10 million deaths by 2050. — Economy
https://www.ecnmy.org/engage/new-antibiotics-arent-made-cause-10-million-deaths-2050/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
New class of antibiotics apparently also works against multi-resistant germs - Innovation Origins
https://innovationorigins.com/new-class-of-antibiotics-apparently-also-works-against-multi-resistant-germs/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Next-gen antibiotic research funded | Mirage News
https://www.miragenews.com/next-gen-antibiotic-research-funded/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics | BioSpace
https://www.biospace.com/article/nosopharm-and-evotec-enter-into-collaboration-to-accelerate-development-of-novel-antibiotics/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants
https://finance.yahoo.com/news/novel-probiotic-strain-dramatically-reduces-100000276.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Novo Holdings REPAIR Impact Fund Invests USD 10 Million in Curza and Spero
https://finance.yahoo.com/news/novo-holdings-repair-impact-fund-140000122.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Novo Holdings invests over $10m in companies developing new antibiotics - EPM Magazine
https://www.epmmagazine.com/news/novo-holdings-invests-over-10m-in/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Oxford Drug Design receives over £8m in grant and equity investment | Cambridge Network
https://www.cambridgenetwork.co.uk/news/oxford-drug-design-receives-over-%C2%A38m-grant-and-equity-investment
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Oxford Drug Design wins UK-China antimicrobial resistance grant - Pharmafield
https://pharmafield.co.uk/pharma_news/oxford-drug-design-wins-uk-china-antimicrobial-resistance-grant/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Panel: Onus to Stop Abx Overuse Is on Prescribers | Medpage Today
https://www.medpagetoday.com/infectiousdisease/publichealth/82703
Antibiotic resistance and pharmaceutical business models
Antimicrobial stewardship
DISARM Act model legislation
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization
https://finance.yahoo.com/news/prokaryotics-receives-2-3-million-123000102.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Qpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
https://finance.yahoo.com/news/qpex-biopharma-first-public-presentations-120000183.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs
RedHill And Talicia In H. Pylori: The PDUFA Countdown - RedHill Biopharma Ltd. (NASDAQ:RDHL) | Seeking Alpha
https://seekingalpha.com/article/4282928-redhill-talicia-h-pylori-pdufa-countdown
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Reducing Use Is Not The Answer: Here Are 5 Ways To Tackle Antibiotic Resistance
https://www.science20.com/news_staff/reducing_use_is_not_the_answer_here_are_5_ways_to_tackle_antibiotic_resistance-238041
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting
https://finance.yahoo.com/news/shionogi-present-cefiderocol-cot-143-143500692.html
Cefiderocol
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Stewardship / Resistance Scan for Jul 17, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/07/stewardship-resistance-scan-jul-17-2019
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Study finds sizable delay in use of new antibiotics | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/07/study-finds-sizable-delay-use-new-antibiotics
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Techulon awarded funding to develop antimicrobial to kill drug-resistant bacteria - Homeland Preparedness News
https://homelandprepnews.com/stories/39542-techulon-awarded-funding-to-develop-antimicrobial-to-kill-drug-resistant-bacteria/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
The Radical Plan to Change How Antibiotics Get Developed | WIRED
https://www.wired.com/story/the-radical-plan-to-change-how-antibiotics-get-developed/
2019-04 Achaogen files for bankruptcy
Pharmaceutical makers, antibiotic resistance and the development of new drugs
UK biotech receives over £8m to advance drug resistant antibiotics - EPM Magazine
https://www.epmmagazine.com/news/uk-biotech-receives-over-8m-to-advance-drug-resistant-antib/
CARB-X
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Unless you act now, antibiotic resistance could kill 10million people by 2050 | Metro News
https://metro.co.uk/2019/05/15/unless-you-act-now-antibiotic-resistance-could-kill-10million-people-by-2050-9493186/
Pharmaceutical makers, antibiotic resistance and the development of new drugs
X-Biotix Therapeutics Joins Antimicrobials Working Group
https://finance.yahoo.com/news/x-biotix-therapeutics-joins-antimicrobials-131300987.html
Pharmaceutical makers, antibiotic resistance and the development of new drugs